Shah Alam Khan

Objective: The aim of the study was to evaluate the role of ¹⁸ F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) in monitoring treatment response and determining treatment end points in patients with extraspinal musculoskeletal tuberculosis (MSK-TB) receiving anti-tubercular therapy (ATT). Methods: In this prospective observational study, 62 patients with extraspinal MSK-TB underwent baseline ¹⁸ F-FDG PET/CT before ATT, with follow-up scans at 6, 12, and 18 months. Total lesion glycolysis (TLG), maximum standardized uptake value (SUVmax), and lesion-to-liver standardized uptake value ratio (SUVR) were recorded. Clinical, laboratory, and MRI findings were used as reference standards for healing. Receiver operating characteristic analysis identified PET/CT parameters associated with ATT beyond 18 months. Results: Fifty-one patients completed the final PET/CT follow-up. Significant reductions in TLG, SUVmax, and SUVR were observed during treatment (all P < 0.05). ROC analysis demonstrated that a ≤43% reduction in TLG, ≤46% reduction in SUVmax, and ≤26% reduction in SUVR between baseline and 6-month scans, and a ≤66% reduction in TLG, ≤36% reduction in SUVmax, and ≤30% reduction in SUVR between baseline and 12-month scans, were associated with the requirement for ATT beyond 18 months. The mean time to complete clinicoradiological healing was 19.23 ± 1.49 months, whereas the mean time to complete metabolic response on PET/CT was 18.54 ± 2.27 months, with no statistically significant difference ( P = 0.30). Conclusion: ¹⁸ F-FDG PET/CT is a valuable tool for monitoring treatment response in extraspinal MSK-TB. Early changes in PET/CT parameters may predict treatment duration, and PET/CT findings closely correlate with disease healing, supporting its use in guiding individualized ATT duration.

This chapter examines the pivotal role of imaging in the diagnosis, staging, treatment planning, and surveillance of bone tumors. Beginning with conventional

This chapter explores the principles, techniques, and outcomes of distal humerus resections and reconstructions, an uncommon but technically demanding procedure

This chapter addresses the surgical management of proximal humerus tumors, a common site of primary and metastatic bone lesions that poses unique challenges due

This chapter reviews the principles, clinical applications, and evolving science of bone grafting in orthopedic oncologic reconstruction. Bone grafts are

This chapter examines the surgical management of distal femur tumors, a region most commonly affected by primary bone malignancies. Historically managed by

This chapter discusses the surgical management of scapular tumors, highlighting the challenges posed by the region's complex anatomy and its critical role in

This chapter addresses the surgical management of tumors of the proximal femur, a region frequently affected by both primary malignant and metastatic lesions.

This chapter explores the surgical management of fibular tumors, a rare subset of bone neoplasms that can involve the proximal, diaphyseal, or distal segments

This chapter provides a comprehensive overview of sacral tumor resections, one of the most technically demanding procedures in musculoskeletal oncology due to